TDB Backs IIT-Delhi Spin-Off’s AI Diagnostic Platform 'Ayukriyam Innovations'
New Delhi, February 26, 2026 – In a significant advancement for indigenous medical technology, the Technology Development Board (TDB), which operates under the Department of Science & Technology (DST), has entered into an agreement with Ayukriyam Innovations Pvt. Ltd. The collaboration aims to support the commercialization of ‘Autoscope’, a fully automated whole slide imaging and AI-driven diagnostic system.
Introduction to Ayukriyam Innovations
Ayukriyam Innovations is a deep-tech spin-off emerging from the Molecular Imaging & Diagnostics Lab within the Department of Biochemical Engineering and Biotechnology at IIT Delhi. The company is dedicated to developing advanced microscopy systems that integrate artificial intelligence to facilitate rapid, accurate, and deployable diagnoses of infectious diseases, particularly in resource-constrained environments.
The Autoscope Platform
The Autoscope platform represents a next-generation digital pathology system that combines automated slide scanning with AI-powered image analytics. This innovative system aims to address critical gaps in India’s pathology infrastructure, where there is a notable shortage of trained pathologists and uneven access to high-end diagnostic facilities, especially outside major urban centers.
Key Features of the Autoscope System
- Fully automated whole slide imaging
- AI-driven diagnostic decision support
- High-throughput and standardized workflows
- Scalable deployment across various laboratories
- Reduced reliance on imported imaging systems
Addressing Gaps in Pathology Infrastructure
India’s healthcare system faces significant challenges, including a shortage of trained professionals and limited access to advanced diagnostic tools. The Autoscope system is designed to bridge these gaps by leveraging indigenous research and development. The platform aims to deliver consistent diagnostic quality while lowering costs and improving turnaround times.
TDB Funding and Support
The financial assistance provided by TDB will facilitate several critical aspects of the project, including:
- Establishment of a dedicated manufacturing facility
- Production of multiple commercial-grade batches
- Comprehensive field performance evaluations
- Market readiness and regulatory compliance
This support is expected to accelerate the transition from prototype to full-scale commercialization, thus strengthening India’s domestic med-tech manufacturing capabilities.
Government Perspective
Shri Rajesh Kumar Pathak, Secretary of TDB, emphasized the importance of this initiative in enhancing India’s healthcare infrastructure. He stated, “Indigenous development of advanced diagnostic platforms that integrate imaging and artificial intelligence is vital for strengthening India’s healthcare ecosystem. Through this support, TDB aims to accelerate the translation of laboratory innovation into market-ready solutions, reduce import dependence, and promote Aatmanirbhar Bharat in the medical technology sector.”
Impact on Healthcare
The promoters of Ayukriyam Innovations have expressed that TDB’s support will significantly enhance the manufacturing readiness and nationwide deployment of the Autoscope platform. This system is particularly timely as India fortifies its disease surveillance systems and expands its digital health infrastructure. AI-enabled pathology tools hold the potential to:
- Improve diagnostic accuracy
- Reduce human error
- Enable remote consultations and telepathology
- Support early detection of infectious diseases
- Lower overall healthcare costs
Reinforcing India’s Deep-Tech Ecosystem
This project exemplifies TDB’s mandate to finance the commercialization of indigenous technologies that emerge from academic research and institutional collaboration. It also reflects a broader government strategy aimed at nurturing high-impact innovations in critical sectors such as healthcare, biotechnology, and medical devices.
As India aspires to become a global hub for affordable medical technology solutions, initiatives like Autoscope underscore the growing synergy between academic research, start-up innovation, and government-backed commercialization support.
Conclusion
The collaboration between TDB and Ayukriyam Innovations marks a pivotal step towards enhancing India’s healthcare infrastructure through advanced technology. By focusing on indigenous solutions, the Autoscope platform not only aims to improve diagnostic capabilities but also to foster self-reliance in the medical technology sector.
Note: The information presented in this article is based on the latest updates as of February 26, 2026. For further developments, please refer to official announcements and news sources.
